Rapid point-of-care COVID-19 test shows promise in clinical study
September 18, 2020 -- A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity and 100% specificity, according to a new study published in the Lancet Microbe.
Discuss
September 18, 2020 -- A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity and 100% specificity, according to a new study published in the Lancet Microbe.
Discuss ProciseDx wins CE Mark for point-of-care tests
September 10, 2020 -- Nestlé Health Science subsidiary ProciseDx has received the European CE Mark for Procise IFX and Procise ADL, the company's infliximab and adalimumab point-of-care diagnostics.
September 10, 2020 -- Nestlé Health Science subsidiary ProciseDx has received the European CE Mark for Procise IFX and Procise ADL, the company's infliximab and adalimumab point-of-care diagnostics.
Qiagen to launch rapid portable SARS-CoV-2 antigen test
September 10, 2020 -- Qiagen plans to launch the Access Anti-SARS-CoV-2 antigen test, a rapid portable test that can detect novel coronavirus antigens in people with active infections in less than 15 minutes.
September 10, 2020 -- Qiagen plans to launch the Access Anti-SARS-CoV-2 antigen test, a rapid portable test that can detect novel coronavirus antigens in people with active infections in less than 15 minutes.
Maxim Biomedical on track to make 3M COVID-19 tests
September 8, 2020 -- Maxim Biomedical plans to produce and market as many as 3 million Maxim SARS-CoV-2 rapid antigen diagnostic tests by the end of the year.
September 8, 2020 -- Maxim Biomedical plans to produce and market as many as 3 million Maxim SARS-CoV-2 rapid antigen diagnostic tests by the end of the year.
NIH to spend $129M to scale up COVID-19 testing
September 2, 2020 -- The U.S. National Institutes of Health (NIH) plans to spend about $129 million to scale up COVID-19 testing capacity and provide manufacturing support. The agency has awarded contracts to nine companies for technologies such as portable point-of-care tests that can provide immediate results and high-throughput labs that can provide results within 24 hours.
September 2, 2020 -- The U.S. National Institutes of Health (NIH) plans to spend about $129 million to scale up COVID-19 testing capacity and provide manufacturing support. The agency has awarded contracts to nine companies for technologies such as portable point-of-care tests that can provide immediate results and high-throughput labs that can provide results within 24 hours.
FDA authorizes Abbott's COVID-19 real-time antigen test
August 27, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for a COVID-19 antigen test developed by Abbott Diagnostics Scarborough from which results can be read directly from the testing card.
August 27, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for a COVID-19 antigen test developed by Abbott Diagnostics Scarborough from which results can be read directly from the testing card.
Qiagen launches 10-minute SARS-CoV-2 test
August 26, 2020 -- Qiagen announced the U.S. launch of a new digital SARS-CoV-2 detection test that can be done on a portable device. The device provides results in about 10 minutes, according to the company.
August 26, 2020 -- Qiagen announced the U.S. launch of a new digital SARS-CoV-2 detection test that can be done on a portable device. The device provides results in about 10 minutes, according to the company.
Point-of-care testing leads South Korea's response to COVID-19
August 24, 2020 -- What was the secret to South Korea's success in controlling the COVID-19 pandemic? A new study indicates that point-of-care testing played an important role in reducing the spread of SARS-CoV-2 there compared to the U.S., which has experienced 47 times the number of cases and almost 80 times the number of deaths.
Discuss
August 24, 2020 -- What was the secret to South Korea's success in controlling the COVID-19 pandemic? A new study indicates that point-of-care testing played an important role in reducing the spread of SARS-CoV-2 there compared to the U.S., which has experienced 47 times the number of cases and almost 80 times the number of deaths.
Discuss Quidel closes Vermont investigation of Sofia test
August 24, 2020 -- Quidel has completed its investigation of false-positive results for COVID-19 at a testing location in Vermont. The company said it found no testing site- or product-related issues with the Sofia 2 instrument or the Sofia immunoassay.
August 24, 2020 -- Quidel has completed its investigation of false-positive results for COVID-19 at a testing location in Vermont. The company said it found no testing site- or product-related issues with the Sofia 2 instrument or the Sofia immunoassay.
Lab-on-a-chip array could provide low-cost SARS-CoV-2 antibody test
August 24, 2020 -- The University of California, Irvine has developed a low-cost lab-on-a-chip test called TinyArray that may be available for rapid COVID-19 diagnostic and antibody testing throughout the U.S. by the end of the year.
August 24, 2020 -- The University of California, Irvine has developed a low-cost lab-on-a-chip test called TinyArray that may be available for rapid COVID-19 diagnostic and antibody testing throughout the U.S. by the end of the year.